98%
921
2 minutes
20
Background: Infusion pumps are critical in delivering fluids, including medications and blood products, in controlled amounts. However, conventional pumps can cause hemolysis and other issues such as flow variations and infection risks, especially during blood transfusions. To address these limitations, a novel cylinder-type infusion pump, the Anyfusion H-100, was developed, which includes a specialized blood transfusion cartridge set that combines syringe and peristaltic infusion methods. This study evaluates the accuracy and hemolysis rates of the Anyfusion H-100 compared to conventional pumps, aiming to confirm its viability as a safe and effective medical device for blood transfusions.
Methods: This study evaluated six different infusion rates (10-180 cc/hr) and conducted 57 transfusion trials, 20 of which used a 1:1 blood-saline dilution. Blood transfusion accuracy was measured using research-grade packed red blood cells, and hemolysis rates were assessed before and after transfusion by chi-square tests and independent sample -tests.
Results: Anyfusion demonstrated an average transfusion error rate of 3.77%, compared to 4.00% for the Terufusion, with no statistically significant difference in hemolysis rates ( = 0.697). Bland-Altman plots confirmed their equivalent performance, with hemolysis rates of 0.566 ± 0.095% for Anyfusion and 0.518 ± 0.126% for Terufusion.
Conclusions: Anyfusion provides an accurate and reliable blood transfusion performance comparable to that of Terufusion, with no significant difference in hemolysis rates; its integration of syringe and infusion methods shows a potential for safer and more efficient transfusion practices, especially in pediatric and emergency settings.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11592363 | PMC |
http://dx.doi.org/10.3390/biomedicines12112421 | DOI Listing |
Medicine (Baltimore)
August 2025
Department of Anaesthesiology, West China Second Hospital, Sichuan University, Chengdu, China.
Rationale: Subcapsular liver hematoma (SLH) during pregnancy is a rare but potentially life-threatening complication, often associated with hypertensive disorders such as preeclampsia and hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome.
Patient Concerns: We report the case of a 37-year-old primipara who presented at 39 weeks of gestation with severe preeclampsia (blood pressure, 166/106 mm Hg; proteinuria, 2+). Notably, her prenatal course was marked by normal blood pressure and 3 negative urine protein tests.
Naunyn Schmiedebergs Arch Pharmacol
September 2025
Experimental Oncology and Hemopathies Laboratory, Clinical Analysis Department, Federal University of Santa Catarina, Florianópolis, Santa Catarina, 88040-900, Brazil.
Burkitt lymphoma (BL) is a germinal center-derived B-cell neoplasm. Due to the aggressiveness of this neoplasm, treatment must be started quickly. Despite innovation in the pharmaceutical industry, BL has high recurrence and mortality rates.
View Article and Find Full Text PDFNiger J Clin Pract
August 2025
Department of Internal Medicine, Ege University Faculty of Medicine, Izmir, Turkey.
Background: Blood testing in the emergency department (ED) is critical for effective patient management. Hemolysis, a common preanalytical error, compromises laboratory results, increases workloads and resource utilization, and causes patient discomfort due to repeat testing.
Aim: This study evaluates the impact of Luer Lock adapters on hemolysis rates in ED blood samples, compared with the standard intravenous injector method.
Int J Mol Sci
August 2025
School of Pharmacy, Walailak University, Nakhon Si Thammarat 80161, Thailand.
Bacterial infection is a cause of life-threatening diseases. The emergence of antimicrobial-resistant bacteria exacerbates this situation, highlighting the need for the discovery of new antimicrobial agents. Our previous study identified a novel antimicrobial peptide, BrSPR20-P1 (P1), which showed potential activity against MRSA.
View Article and Find Full Text PDFBiomolecules
July 2025
Key Laboratory of Chemo/Biosensing and Detection of Xuchang, Key Laboratory of Micro-Nano Materials for Energy Storage and Conversion of Henan Province, Henan Joint International Research Laboratory of Nanomaterials for Energy and Catalysis, College of Chemical and Materials Engineering, Xuchang Uni
In the context of critical challenges in curcumin-modified polyurethane synthesis-including limited curcumin bioavailability and suboptimal biodegradability/biocompatibility-a novel polyurethane material (Cur-PU) with good mechanical, shape memory, pH-responsive, and biocompatibility was synthesized via a one-pot, two-step synthetic protocol in which HO-PCL-OH served as the soft segment and curcumin was employed as the chain extender. The experimental results demonstrate that with the increase in Cur units, the crystallinity of the Cur-PU material decreases from 32.6% to 5.
View Article and Find Full Text PDF